Filiz Senbabaoglu
Istanbul, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Drug Repositioning Screen on a New Primary Cell Line Identifies Potent Therapeutics for Glioblastoma.
Journal: Frontiers in neuroscience
Published: June 30, 2020
The pro-apoptotic Bcl-2 family member Harakiri (HRK) induces cell death in glioblastoma multiforme.
Journal: Cell death discovery
Published: October 08, 2018
KDM2B, an H3K36-specific demethylase, regulates apoptotic response of GBM cells to TRAIL.
Journal: Cell death & disease
Published: January 06, 2017
A platinum blue complex exerts its cytotoxic activity via DNA damage and induces apoptosis in cancer cells.
Journal: Chemical biology & drug design
Published: July 11, 2016
Identification of Mitoxantrone as a TRAIL-sensitizing agent for Glioblastoma Multiforme.
Journal: Cancer biology & therapy
Published: April 01, 2016
Cytotoxicity and mitogenicity assays with real-time and label-free monitoring of human granulosa cells with an impedance-based signal processing technology intergrating micro-electronics and cell biology.
Journal: Reproductive toxicology (Elmsford, N.Y.)
Published: September 21, 2015
GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.
Journal: Human reproduction (Oxford, England)
Published: June 17, 2015
The magnitude of gonadotoxicity of chemotherapy drugs on ovarian follicles and granulosa cells varies depending upon the category of the drugs and the type of granulosa cells.
Journal: Human reproduction (Oxford, England)
Published: June 11, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026